Joel Dziengielewski is a Director with the Healthcare and Life Sciences Disputes, Compliance and Investigation (HLS-DCI) practice. Joel advises clients on the design, evaluation and implementation of ethics and compliance programs, as well as on the design and evaluation of anti-fraud programs and controls as outlined by various governance frameworks including the United States Federal Sentencing Guidelines, the COSO Integrated Framework, US Health and Human Services Office of the Inspector General Compliance Program Guidance, New York State OMIG Compliance Program Guidance, and SAS 99. Joel has advised clients in healthcare including providers and payors, pharmaceuticals, orthopedics, medical devices and select other industries.